DPI-221

DPI-221
Gene therapy
Clinical data
Physiological data
Legal status
Pharmacokinetic data
Identifiers
	IUPAC name 4-((αS)-α-((2S,5R)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide;
PubChem Template:Abbreviation	9891642;
Chemical and physical data
Formula	C21H38FN3O
Molar mass	487.65 g/mol
3D model (JSmol)	Interactive image;
	SMILES c2ccccc2C(c(cc4)ccc4C(=O)N(CC)CC)N(CC1C)C(C)CN1Cc(c3)cccc3F;

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

DPI-221 is a drug which is used in scientific research. It is a highly selective agonist for the δ-opioid receptor which produces less convulsions than most drugs from this family.^[1]

References

↑ Holt JD, Watson MJ, Chang JP, O'Neill SJ, Wei K, Pendergast W, Gengo PJ, Chang KJ. DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats. Journal of Pharmacology and Experimental Therapeutics. 2005 Nov;315(2):601-8. PMID 16020629

Template:Opioids

Template:WikiDoc Sources

[1] Holt JD, Watson MJ, Chang JP, O'Neill SJ, Wei K, Pendergast W, Gengo PJ, Chang KJ. DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats. Journal of Pharmacology and Experimental Therapeutics. 2005 Nov;315(2):601-8. PMID 16020629

[1]

DPI-221

Overview

References

Navigation menu

Search